The reformulated vaccine defends against new omicron strains, including XBB omicron variants. The panel stopped short of ...

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here's what we know.

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

The FDA has used separate emergency powers to authorize the Pfizer, Moderna, Johnson & Johnson and Novavax vaccines.

It's part of a plan to offer a single booster to the public each year that gives protection against the most recent, dominant ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

California state leaders seem to be quietly closing the door on the Covid-19 vaccine mandate for school children. The California Department of Public Health hasn’t made an announcement, but officials ...

The Food and Drug Administration’s independent vaccine advisory committee voted unanimously in favor of having all COVID-19 vaccines in the United States use the same formulation as the two-strain ...

The CDC and FDA announced ... the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...